NOME Trademark

Trademark Overview


On Saturday, April 19, 2025, a trademark application was filed for NOME with the United States Patent and Trademark Office. The USPTO has given the NOME trademark a serial number of 99145505. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Saturday, April 19, 2025. This trademark is owned by Nome Therapeutics, Inc.. The NOME trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Software as a service (SAAS) services featuring software for drug development, custom drug development, and personalized anti-sense RNA drug development; Software as a service (SAAS) services featuring software for using artificial intelligence (AI) for drug development, custom drug development, and personalized anti-sense RNA drug development; Platform as a service (PAAS) featuring computer software platforms for drug development, custom drug development, and personalized anti-sense RNA drug development; Platform as a service (PAAS) featuring computer software platforms for drug development, custom drug development, and personalized anti-sense RNA drug development, all of the foregoing using artificial intelligence (AI)
nome

General Information


Serial Number99145505
Word MarkNOME
Filing DateSaturday, April 19, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateSaturday, April 19, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesSoftware as a service (SAAS) services featuring software for drug development, custom drug development, and personalized anti-sense RNA drug development; Software as a service (SAAS) services featuring software for using artificial intelligence (AI) for drug development, custom drug development, and personalized anti-sense RNA drug development; Platform as a service (PAAS) featuring computer software platforms for drug development, custom drug development, and personalized anti-sense RNA drug development; Platform as a service (PAAS) featuring computer software platforms for drug development, custom drug development, and personalized anti-sense RNA drug development, all of the foregoing using artificial intelligence (AI)

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, April 19, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNome Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChicago, IL 60614

Trademark Events


Event DateEvent Description
Saturday, April 19, 2025NEW APPLICATION ENTERED
Saturday, April 19, 2025APPLICATION FILING RECEIPT MAILED